Original Research
Published on 01 May 2018
Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2018.00932
- 14,793 views
- 38 citations
